Efficacy and safety of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) monotherapy for advanced EGFR-mutated non-small cell lung cancer: systematic review and meta-analysis.
Lee HJ, Jeong GH, Li H, Kim MS, Kim JS, Park SJ, Han YJ, Lee KH, Kronbichler A, Hong SH, Ghayda RA, Luchini C, Nottegar A, Koyanagi A, Smith L, Jacob L, Dragioti E, Radua J, Cargnin S, Terrazzino S, Thompson T, Yon DK, Lee SW, Yang JM, Wasuwanich P, Shin JI, Gamerith G.
Lee HJ, et al. Among authors: cargnin s.
Eur Rev Med Pharmacol Sci. 2021 Oct;25(20):6232-6244. doi: 10.26355/eurrev_202110_26993.
Eur Rev Med Pharmacol Sci. 2021.
PMID: 34730203
Free article.